Novartis Ag

Cisco Technology, Inc.

Shanghai United Imaging Healthcare Co., Ltd.

Shanghai Unicar-therapy Bio-medicine Technology Co., Ltd

Wei Qi

Martin Sendzik

Lei Li

Ling Li

Qiong Zhang

Long Wang

Yuan Mi

Zhengtian Yu

Xiang-Ju Justin Gu

Ho Man Chan

Yongfeng Sun

Man Zhang

Hailong Zhang

Kehao Zhao

Ji Yue (Jeff) Zhang

Yun Yu Wang

Jian Ming Liu

Lei Yu

Zhou Yu

Ji Yue Zhang

Liqing Kang

Xingnian Fu

Gaowu Lin

Huang Yan

Jian Zhang

Vic Hong Chia

Julien Papillon

Jiamin Li

Yifeng Wang

Hua Yang

Yongguo Chen

Michael Dore

Counde Oyang

Xiaoxia Yan

Kun Chin Liu

Xiaobin Li

Xuan Dai

Jianning Zhang

Hujiao Wang

Yong Hong Luo

John MacKay

Benjamin Lee Davis

David A Holtzclaw

Jiayou Meng

Ying Huang

Ronghua Xia

Sing Yeung Frankie Mak

The present disclosure relates to a cavity of a medical device. The cavity may include a bore and an accommodating cavity configured to provide an accommodating space for at least a portion of a couch in a radial direction of the bore. The accommodating cavity may be disposed on an inner wall of the bore and extend along an axial direction of the bore, and the accommodating cavity may be configured to form, with the bore, a connected space in which the at least a portion of the couch is allowed to move along an axial direction of the bore.

Cavity of medical device and medical system including the medical device

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R, R, R, R, R, and n are as defined herein.

Triazolopyrimidine compounds and uses thereof

Embodiments for providing cooling airflow through electronic in two different directions is described. An airflow control louver system in an electronic device provides for cooling airflow to be efficiently routed through the electronic device in the two different directions which in turn allows for multiple installation configurations for electronic devices with high powered heat sensitive components.

Airflow control louver for bidirectional airflow cooling

A device and system for supporting a patient or an object in an examination is provided. The supporting system may include a portion for supporting the body of a patient and/or a head supporting device. The portion for supporting the body may move in one or more directions. The head supporting device may be adjust to meet requirements of imaging when the patient or the object is supine or prone.

Supporting device in medical diagnostics system

An OCTS-based CAR-T vector for treating pancreatic cancer and malignant mesothelioma includes lentiviral skeleton plasmid, human EF1&#x3b1; promoter (SEQ ID NO: 14), OCTS chimeric receptor structural domain, and PDL1 single-chain antibody; the OCTS chimeric receptor structural domain consists of CD8 leader chimeric receptor signal peptide (SEQ ID NO: 15), PDL1 single-chain antibody light chain VL (SEQ ID NO: 16), PDL1 single-chain antibody heavy chain VH (SEQ ID NO: 17), mesothelin single-chain antibody light chain VL (SEQ ID NO: 18), mesothelin single-chain antibody heavy chain VH (SEQ ID NO: 19), antibody Inner-Linker (SEQ ID NO: 20), single-chain antibody Inter-Linker (SEQ ID NO: 21), CD8 Hinge chimeric receptor linker (SEQ ID NO: 22), CD8 Transmembrane chimeric receptor transmembrane domain (SEQ ID NO: 23), TCR chimeric receptor T cell activation domain (SEQ ID NO: 26) and chimeric receptor co-stimulator domain.

OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof

Disclosed are apparatuses including a cable header block with apertures for floating inserts and a cover plate. The cable header block includes an aperture pattern that matches a pattern of connector terminals. The floating inserts fit in the apertures of the cable header block. The cover plate can also include a through-hole pattern that matches the aperture pattern. Also, each of the through-holes can include a first geometric shape larger than a cross-section of a cable terminal end and a second geometric shape adjacent to the first shape that is smaller than the cross-section of the cable terminal end. The cover plate retains the floating inserts within the apertures. Also, the cover plate aligns the first geometric shape over the floating inserts when the fastener is in a first position and aligns the second geometric shape over the floating inserts when the fastener is in a second position.

Cable header

An OCTS-based CAR-T vector for treating malignant glioma includes lentiviral skeleton plasmid, human EF1&#x3b1; promoter (SEQ ID NO.14), OCTS chimeric receptor structural domain, and PDL1 single-chain antibody; the OCTS chimeric receptor structural domain consists of CD8 leader chimeric receptor signal peptide (SEQ ID NO.15), PDL1 single-chain antibody light chain VL (SEQ ID NO.16), PDL1 single-chain antibody heavy chain VH (SEQ ID NO.17), EGFRvIII single-chain antibody light chain VL (SEQ ID NO.18), EGFRvIII single-chain antibody heavy chain VH (SEQ ID NO.19), antibody Inner-Linker (SEQ ID NO.20), single-chain antibody Inter-Linker (SEQ ID NO.21), CD8 Hinge chimeric receptor linker (SEQ ID NO.22), CD8 Transmembrane chimeric receptor transmembrane domain (SEQ ID NO.23), TCR chimeric receptor T cell activation domain (SEQ ID NO.26) and chimeric receptor co-stimulator domain.

Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R, Rand Rare as defined herein.

Triazolopyridine compounds and uses thereof

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R, R, R, and Rare as defined herein.

Imidazolepyridine compounds and uses thereof

In one implementation, an apparatus includes a securing component configured to attach the line card ejector to a chassis of a network communication device, prevent removal of a line card from the chassis when the securing component is in a first configuration, and allow removal of the line card from the chassis when the securing component is in a second configuration. The apparatus also includes an ejection component configured to facilitate insertion and removal of the line card from the chassis of the network communication device. The apparatus further includes a sensor component configured to detect an imminent removal of the line card from the chassis of the network communication device.

Line card ejector with line card removal indication

Growing community of inventors

Shanghai, China

Wei Qi